Privia Health Group, Inc. — Form 8-K Summary
Business context and reporting period
This Form 8-K, dated May 9, 2023 and signed May 10, 2023, reports a governance change following a registered secondary offering of Privia Health Group, Inc. common stock.
Material event and governance changes
- On May 8, 2023, affiliates of Goldman Sachs and Pamplona Capital Management completed a registered secondary offering and sale of the Company’s common stock.
- Following the offering, the Lead Investors no longer beneficially owned securities representing at least 25% of the voting power generally entitled to vote in director elections.
- Effective May 9, 2023, the Company’s Board became divided into three approximately equal classes with staggered three-year terms under the amended and restated organizational documents.
Board classification
| Class | Initial term expires | Directors |
|---|---|---|
| Class I | 2023 annual meeting | Jeff Bernstein; Nancy Cocozza; David King |
| Class II | 2024 annual meeting | Thomas McCarthy; Jaewon Ryu, M.D.; Bill Sullivan |
| Class III | 2025 annual meeting | Patricia Maryland; Shawn Morris; Will Sherrill |
Financial metrics, outlook, and risks
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, operating guidance, or other financial metrics. It does not disclose new financial contingencies or unusual operating items. The principal reported change is the transition to a classified, staggered Board following the reduction in the Lead Investors’ voting ownership.
Important facts for investors to verify
- Review the secondary offering documents for the number of shares sold, selling prices, and any continuing ownership or registration rights.
- Confirm the amended and restated certificate of incorporation and bylaws governing the classified Board structure.
- Monitor the 2023, 2024, and 2025 annual meetings for director elections and potential effects on Board continuity and shareholder voting dynamics.